37 In the index

Insulin glargine GLAR

A long-acting insulin (Lantus) approved for diabetes and one of the most widely used insulins in the world. Extensive real-world and clinical evidence confirms reliable, all-day blood sugar control with a well-understood risk of low blood sugar.

Also known as Lantus

Effects Build muscle

Routes Subcutaneous

Legal status Prescription drug

WADA Banned at all times

Reported dosing

Approved label

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Individualized, once-daily basal dosing (as prescribed)

Reported range Highly variable by patient

Route Subcutaneous injection

Frequency Once daily

Duration Chronic/ongoing (as prescribed)

FDA-approved long-acting basal insulin (Lantus/Basaglar); same severe hypoglycemia risk applies to any non-medical use.

Where this comes from FDA prescribing information

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.